Australia
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 14.69 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
2 |
USD 11.11 B
|
June 30, 2024 | USD 21.27 | 2.57% |
|
Australia |
|
3 |
USD 8.79 B
|
June 30, 2024 | USD 20.43 | 1.47% |
|
Australia |
|
4 |
USD 5.96 B
|
June 30, 2024 | USD 17.28 | 1.26% |
|
Australia |
|
5 |
USD 5.35 B
|
June 30, 2024 | USD 2.35 | 0.77% |
|
Australia |
|
6 |
USD 2.18 B
|
Jan. 31, 2024 | USD 1.81 | -0.44% |
|
Australia |
|
7 |
USD 1.62 B
|
June 30, 2024 | USD 21.11 | 1.40% |
|
Australia |
|
8 |
USD 1.16 B
|
June 30, 2024 | USD 0.87 | 0.96% |
|
Australia |
|
9 |
USD 676.13 M
|
June 30, 2024 | USD 3.89 | 3.70% |
|
Australia |
|
10 |
USD 459.88 M
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
11 |
USD 338.23 M
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
12 |
USD 313.18 M
|
June 30, 2024 | USD 1.81 | -0.10% |
|
Australia |
|
13 |
USD 258.80 M
|
June 30, 2024 | USD 2.80 | 2.04% |
|
Australia |
|
14 |
USD 170.00 M
|
June 30, 2024 | USD 0.76 | 1.07% |
|
Australia |
|
15 |
USD 118.63 M
|
June 30, 2024 | USD 1.21 | 0.76% |
|
Australia |
|
16 |
USD 114.39 M
|
June 30, 2024 | USD 2.01 | -0.68% |
|
Australia |
|
17 |
USD 107.68 M
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
18 |
USD 107.67 M
|
June 30, 2024 | USD 0.84 | -1.22% |
|
Australia |
|
19 |
USD 103.36 M
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
20 |
USD 74.15 M
|
June 30, 2024 | USD 0.71 | 1.12% |
|
Australia |
|
21 |
USD 68.80 M
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
22 |
USD 58.79 M
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
23 |
USD 18.48 M
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
24 |
USD 14.71 M
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
25 |
USD 7.67 M
|
June 30, 2024 | USD 2.37 | 1.84% |
|
Australia |
|
26 |
USD 5.90 M
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
27 |
USD 3.27 M
|
June 30, 2024 | USD 2.00 | 1.52% |
|
Australia |
|
28 |
USD 2.80 M
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
|
29 |
USD 2.68 M
|
June 30, 2024 | USD 3.31 | -4.06% |
|
Australia |
|
30 |
USD 2.56 M
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
31 |
USD 1.54 M
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
|
32 |
USD 124.67 K
|
June 30, 2024 | USD 3.82 | 6.70% |
|
Australia |
|
33 |
USD 12.00 K
|
June 30, 2024 | USD 1.77 | -1.67% |
|
Australia |
The Health Care company in Australia with the highest Revenue is CSL Limited (ASX: CSL.AX) at USD 14.69 B.
The Health Care company in Australia with the lowest Revenue is Incannex Healthcare Limited (NasdaqGM: IXHL) at USD 12.00 K.
The top 10 Health Care companies in Australia by Revenue are CSL Limited, Ramsay Health Care Limited, EBOS Group Limited, Sonic Healthcare Limited, Medibank Private Limited, Sigma Healthcare Limited, Ansell Limited, Healius Limited, Regis Healthcare Limited and Australian Clinical Labs Limited.
The bottom 10 Health Care companies in Australia by Revenue are Incannex Healthcare Limited, Opthea Limited, Kazia Therapeutics Limited, Immutep Limited, Alterity Therapeutics Limited, Anteris Technologies Ltd, Immuron Limited, Mesoblast Limited, Clarity Pharmaceuticals Ltd and PYC Therapeutics Limited.